Dr. Sattva Neelapu, MD
Claim this profileMD Anderson Cancer Center
Studies Lymphoma
Studies B-Cell Lymphoma
5 reported clinical trials
6 drugs studied
Affiliated Hospitals
Clinical Trials Sattva Neelapu, MD is currently running
ADI-001
for Non-Hodgkin's Lymphoma
This is a Phase 1 dose escalation study following a 3+3 study design. The purpose of this study is to evaluate the safety and efficacy of ADI-001 in patients with B cell malignancies.
Recruiting1 award Phase 1
SC291
for B-Cell Malignancies
This trial tests SC291, a new drug for blood cancers, in patients with NHL or CLL who have tried multiple treatments. SC291 is given after chemotherapy to better target cancer cells.
Recruiting1 award Phase 110 criteria
More about Sattva Neelapu, MD
Clinical Trial Related4 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Sattva Neelapu, MD has experience with
- JV-213
- Leukapheresis
- ADI-001
- PBCAR20A
- SC291
- CRG-022
Breakdown of trials Sattva Neelapu, MD has run
Lymphoma
B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Chronic B-Cell Leukemia
Chronic Lymphocytic Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sattva Neelapu, MD specialize in?
Sattva Neelapu, MD focuses on Lymphoma and B-Cell Lymphoma. In particular, much of their work with Lymphoma has involved treating patients, or patients who are undergoing treatment.
Is Sattva Neelapu, MD currently recruiting for clinical trials?
Yes, Sattva Neelapu, MD is currently recruiting for 3 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Sattva Neelapu, MD has studied deeply?
Yes, Sattva Neelapu, MD has studied treatments such as JV-213, Leukapheresis, ADI-001.
What is the best way to schedule an appointment with Sattva Neelapu, MD?
Apply for one of the trials that Sattva Neelapu, MD is conducting.
What is the office address of Sattva Neelapu, MD?
The office of Sattva Neelapu, MD is located at: MD Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the MD Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.